MACROH2A1 and myelodysplastic syndrome: These data provide evidence that macroH2A1.1 mRNA tends to decrease in the BM of MDS patients carrying the U2AF1 S34F mutation and that both macroH2A1.1 isoforms’ transcript levels are decreased in the BM of MDS patients who are del(5q) carriers.